Cited 0 time in
Intractable pneumococcal meningoencephalitis associated with a TNF-alpha antagonist
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kang, Seok-Jae | - |
| dc.contributor.author | Kim, Hyun Young | - |
| dc.contributor.author | Kim, Young Seo | - |
| dc.contributor.author | Lee, Ha Neul | - |
| dc.contributor.author | Kim, Hee Tae | - |
| dc.contributor.author | Kim, Seung H. | - |
| dc.date.accessioned | 2022-07-16T03:27:25Z | - |
| dc.date.available | 2022-07-16T03:27:25Z | - |
| dc.date.issued | 2014-09 | - |
| dc.identifier.issn | 0022-510X | - |
| dc.identifier.issn | 1878-5883 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/159256 | - |
| dc.description.abstract | A 34-year-old man was treated with a TNF-alpha antagonist for ankylosing spondylitis, and this subsequently developed a CNS infection. Magnetic resonance imaging showed diffuse subcortical white matter lesions. Streptococcus pneumoniae was cultured from the cerebrospinal fluid and blood. The patient died of multifocal widespread brain damage and subarachnoid hemorrhage, despite intensive antibacterial medication. Pneumococcal meningoencephalitis can occur in association with TNF-alpha antagonists. Clinicians should be aware of both the risk of fatal bacterial meningoencephalitis associated with TNF-alpha antagonists and the possibility of an unusual presentation of bacterial meningitis. | - |
| dc.format.extent | 4 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier BV | - |
| dc.title | Intractable pneumococcal meningoencephalitis associated with a TNF-alpha antagonist | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.jns.2014.05.038 | - |
| dc.identifier.scopusid | 2-s2.0-84906794177 | - |
| dc.identifier.wosid | 000341899400038 | - |
| dc.identifier.bibliographicCitation | Journal of the Neurological Sciences, v.344, no.1-2, pp 215 - 218 | - |
| dc.citation.title | Journal of the Neurological Sciences | - |
| dc.citation.volume | 344 | - |
| dc.citation.number | 1-2 | - |
| dc.citation.startPage | 215 | - |
| dc.citation.endPage | 218 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Neurosciences & Neurology | - |
| dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
| dc.relation.journalWebOfScienceCategory | Neurosciences | - |
| dc.subject.keywordPlus | WHITE-MATTER LESIONS | - |
| dc.subject.keywordPlus | STREPTOCOCCUS-PNEUMONIAE | - |
| dc.subject.keywordPlus | BACTERIAL-MENINGITIS | - |
| dc.subject.keywordPlus | INFLIXIMAB | - |
| dc.subject.keywordPlus | DISORDERS | - |
| dc.subject.keywordPlus | INJURY | - |
| dc.subject.keywordPlus | RISK | - |
| dc.subject.keywordAuthor | Streptococcus pneumoniae | - |
| dc.subject.keywordAuthor | Meningoencephalitis | - |
| dc.subject.keywordAuthor | TNF-alpha antagonist | - |
| dc.subject.keywordAuthor | Infliximab | - |
| dc.subject.keywordAuthor | White matter | - |
| dc.subject.keywordAuthor | Bacterial meningitis | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0022510X14003281?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
